An independent expert panel of the US Food and Drug Administration (FDA) approved the vaccine against COVID-19. Of Johnson & Johnson (J&J) for emergency use
–
The US Food and Drug Administration (FDA) has approved the vaccine against COVID-19. For emergency use on Saturday, J&J was the third vaccine licensed for use on Saturday. Emergency (EUA) in the US follows Pfizer-Biontec vaccine. And of Moderna
U.S. to approve vaccine Johnson & Johnson
A minute of history! Inject the first dose of the COVID-19 vaccine “Anutin” and start “Sinovac”
The J&J vaccine is the “Ad26.COV2.S” or “JNJ-78436735” vaccine developed by Janssen. Which is a Johnson & Johnson biotechnology company For the prevention of COVID-19 in the country and is also It is the first “single-dose vaccine” to be used in the United States. And it is allowed to be distributed to people aged 18 and over.
By the results of clinical research in the third phase Conducted worldwide with 44,000 people, the vaccine reduced hospitalizations by 100% within 28 days after vaccination. However, calculated within a 14-day time frame, the protective effectiveness was 85%, while the overall effectiveness was 66.1% in moderate to severe COVID-19 resistance.
In addition, the COVID-19 vaccine Of Johnson & Johnson That is injected only once and can be stored in the refrigerator It is also more cost effective and easier to transport. This compares with Pfizer and Modena vaccines previously approved by the FDA.
– – .
